Publications of Christoph W. Turck

Misiewicz, R. Z.; Iurato, S.; Kulesskaya, N.; Salminen, L.; Rodrigues, L.; Maccarrone, G.; Martins, J.; Czamara, D.; Laine, M. A.; Sokolowska, E. et al.; Trontti, K.; Rewerts, C.; Novak, B.; Volk, N.; Park, D. I.; Jokitalo, E.; Paulin, L.; Auvinen, P.; Voikar, V.; Chen, A.; Erhardt, A.; Turck, C. W.; Hovatta, I.: Multi-omics analysis identifies mitochondrial pathways associated with anxiety-related behavior. PLoS Genetics 15 (9), e1008358 (2019)

Ising, M.; Maccarrone, G.; Brueckl, T.; Scheuer, S.; Hennings, J.; Holsboer, F.; Turck, C. W.; Uhr, M.; Lucae, S.: FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 20 (3), 485 (2019)

Martins, J.; Czamara, D.; Lange, J.; Dethloff, F.; Binder, E. B.; Turck, C. W.; Erhardt, A.: Exposure-induced changes of plasma metabolome and gene expression in patients with panic disorder. DEPRESSION AND ANXIETY 36 (12), pp. 1173 - 1181 (2019)

Papadopoulou, Z.; Vlaikou, A.-M.; Theodoridou, D.; Komini, C.; Chalkiadaki, G.; Vafeiadi, M.; Margetaki, K.; Trangas, T.; Turck, C. W.; Syrrou, M. et al.; Chatzi, L.; Filiou, M. D.: Unraveling the Serum Metabolomic Profile of Post-partum Depression. FRONTIERS IN NEUROSCIENCE 13, 833 (2019)

Golub, M. S.; Hogrefe, C. E.; Sherwood, R. J.; Turck, C. W.: Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children. FRONTIERS IN PEDIATRICS 6, 21 (2018)

Ko, H.-G.; Choi, J.-H.; Park, D. I.; Kang, S. J.; Lim, C.-S.; Sim, S.-E.; Shim, J.; Kim, J.-I.; Kim, S.; Choi, T.-H. et al.; Ye, S.; Lee, J.; Park, P.; Kim, S.; Do, J.; Park, J.; Islam, M. A.; Kim, H. J.; Turck, C. W.; Collingridge, G. L.; Zhuo, M.; Kaang, B.-K.: Rapid Turnover of Cortical NCAM1 Regulates Synaptic Reorganization after Peripheral Nerve Injury. CELL REPORTS 22 (3), pp. 748 - 759 (2018)

Park, D. I.; Stambuk, J.; Razdorov, G.; Pucic-Bakovic, M.; Martins-de-Souza, D.; Lauc, G.; Turck, C. W.: Blood plasma/IgG N-glycome biosignatures associated with major depressive disorder symptom severity and the antidepressant response. SCIENTIFIC REPORTS 8, 179 (2018)

Gassen, N. C.; Hartmann, J.; Zannas, A. S.; Kretzschmar, A.; Zschocke, J.; Maccarrone, G.; Hafner, K.; Zellner, A.; Kollmannsberger, L. K.; Wag, K. V. et al.; Mehta, D.; Kloiber, S.; Turck, C. W.; Lucae, S.; Chrousos, G. P.; Holsboer, F.; Binder, E. B.; Ising, M.; Schmidt, M. V.; Rein, T.: FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY 21 (2), pp. 277 - 289 (2016)

Park, D. I.; Turck, C. W.: Interactome Studies of Psychiatric Disorders. In: REVIEWS ON BIOMARKER STUDIES IN PSYCHIATRIC AND NEURODEGENERATIVE DISORDERS, pp. 163 - 173 (2019)

Contini, C.; Serrao, S.; Manconi, B.; Olianas, A.; Guadalupi, G.; Iavarone, F.; Bizzarro, A.; Messana, I.; Castagnola, M.; Masullo, C. et al.; Maccarrone, G.; Turck, C.; Cabras, T.: Characterization of cystatin B interactome in saliva of Alzheimer's disease patients. In FEBS OPEN BIO, 12, p. 31 - 31. (2022)

Naamanka, J.; Tasanko, E.; Trontti, K.; Novak, B.; Suvisaari, J.; Paunio, T.; Vaht, M.; Mattheisen, M.; Meier, S.; Metspalu, A. et al.; Daly, M.; Erhardt-Lehmann, A.; Turck, C. W.; Hartiala, J. A.; Hovatta, I.: GENOME-WIDE ANALYSIS IDENTIFIES SORCS3 AS A NOVEL SUSCEPTIBILITY LOCUS FOR PANIC DISORDER IN THE FINNGEN STUDY. In EUROPEAN NEUROPSYCHOPHARMACOLOGY, 63, p. E101 - E101. (2022)

Papadopoulou, Z.; Vlaikou, A.-M.; Theodoridou, D.; Markopoulos, G. S.; Tsoni, K.; Agakidou, E.; Drosou-Agakidou, V.; Turck, C. W.; Filiou, M. D.; Syrrou, M.: Stressful Newborn Memories: Pre-Conceptual, In Utero, and Postnatal Events. FRONTIERS IN PSYCHIATRY 10, 220 (2019)

Zhang, L.; Turck, C. W.; Wang, G.-Z.: Editorial: Time, genetics, and complex disease. FRONTIERS IN GENETICS 13, 1016049 (2022)